US Stock MarketDetailed Quotes

ORIAW ORION BIOTECH OPPORTUNITIES CORP C/WTS 15/04/2025 (TO PUR COM)

Watchlist
  • 0.006
  • 0.0000.00%
15min DelayClose Apr 28 16:00 ET
0Market Cap0.00P/E (TTM)

ORION BIOTECH OPPORTUNITIES CORP C/WTS 15/04/2025 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-376.76K
-5.31K
-77.52K
-157.35K
-136.57K
Net income from continuing operations
--8.76M
--1.29M
--920.26K
--1.93M
--4.62M
Operating gains losses
---9.66M
---1.49M
---1.13M
---2.13M
---4.9M
Change In working capital
--522.92K
--198.21K
--127.94K
--47.17K
--149.59K
-Change in prepaid assets
--466.96K
--118.59K
--110.26K
--116.93K
--121.18K
-Change in payables and accrued expense
--55.96K
--79.62K
--17.68K
---69.75K
--28.41K
Cash from discontinued investing activities
Operating cash flow
---376.76K
---5.31K
---77.52K
---157.35K
---136.57K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
-70K
-70K
0
Net issuance payments of debt
--0
--0
--0
----
----
Net common stock issuance
--0
--0
--0
----
----
Net other financing activities
---70K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
---70K
---70K
--0
----
----
Net cash flow
Beginning cash position
--712.47K
--341.03K
--418.55K
--575.9K
--712.47K
Current changes in cash
---446.76K
---75.31K
---77.52K
---157.35K
---136.57K
End cash Position
--265.72K
--265.72K
--341.03K
--418.55K
--575.9K
Free cash flow
---376.76K
---5.31K
---77.52K
---157.35K
---136.57K
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -376.76K-5.31K-77.52K-157.35K-136.57K
Net income from continuing operations --8.76M--1.29M--920.26K--1.93M--4.62M
Operating gains losses ---9.66M---1.49M---1.13M---2.13M---4.9M
Change In working capital --522.92K--198.21K--127.94K--47.17K--149.59K
-Change in prepaid assets --466.96K--118.59K--110.26K--116.93K--121.18K
-Change in payables and accrued expense --55.96K--79.62K--17.68K---69.75K--28.41K
Cash from discontinued investing activities
Operating cash flow ---376.76K---5.31K---77.52K---157.35K---136.57K
Investing cash flow
Cash flow from continuing investing activities 000
Cash from discontinued investing activities
Investing cash flow --0--0--0--------
Financing cash flow
Cash flow from continuing financing activities -70K-70K0
Net issuance payments of debt --0--0--0--------
Net common stock issuance --0--0--0--------
Net other financing activities ---70K----------------
Cash from discontinued financing activities
Financing cash flow ---70K---70K--0--------
Net cash flow
Beginning cash position --712.47K--341.03K--418.55K--575.9K--712.47K
Current changes in cash ---446.76K---75.31K---77.52K---157.35K---136.57K
End cash Position --265.72K--265.72K--341.03K--418.55K--575.9K
Free cash flow ---376.76K---5.31K---77.52K---157.35K---136.57K
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg